Benitec Limited and CCIA Collaborate on an RNAi Therapeutic for Lung Cancer

Melbourne, Oct 1, 2009 (ABN Newswire) - The Directors of Benitec Limited (ASX:BLT)(PINK:BNIKF) are delighted to announce a collaboration with the Children’s Cancer Institute Australia for Medical Research (CCIA) for the development of an RNAi therapeutic for lung cancer. Children’s Cancer Institute Australia for Medical Research is affiliated with the University of New South Wales and Sydney Children’s Hospital.

MORE ON THIS TOPIC